Navigation Links
AMD discovery: New hope for treatment of vision loss
Date:2/20/2008

This release is available in French.

Montreal, February 20, 2008 Scientists have won a major battle in the fight against age-related macular degeneration, or AMD, a blinding eye disease that affects millions of people. An international team, led by researchers at Sainte-Justine Hospital and the Universit de Montral, has identified the deficient receptor that causes the dry form of AMD.

In the February edition of the medical journal PLoS Medicine, the researchers explain how a deficiency of the CD36 receptor prevents the evacuation of oxidized lipids in the eye. Those oxidized lipids in turn accumulate and attack the layers beneath and over the retina thereby causing vision loss.

Our discovery has important implications for the development of new therapies, explains lead researcher, Dr. Sylvain Chemtob, who co-authored the paper with Universit de Montral collaborator Dr. Huy Ong, a professor at the Faculty of Pharmacy, as well as Florian Sennlaub of the Institut national de la sant et de la recherche mdicale (INSERM) in France.

Chemtob, a neonatal researcher at Sainte-Justine Hospital and a professor at the Universit de Montrals Department of Pediatrics and School of Optometry, used mice and rat models to pinpoint the scavenger receptor responsible for retinal degeneration typical of dry AMD. We found that a deficiency in CD36 receptors leads to significant and progressive age-related macular degeneration, he says. CD36 deficiency leads to central vision loss a key feature of dry AMD.

This discovery brings us one step closer to treating dry AMD, which could significantly improve the quality of life of seniors who are most affected by this eye disease, added co-author Dr. Huy Ong. Now that we have also developed the molecules that activate CD 36 receptor, we are working on the validation of the efficacy of these molecules as potential therapeutic agents for dry AMD treatment with pros
'/>"/>

Contact: Sylvain-Jacques Desjardins
sylvain-jacques.desjardins@umontreal.ca
514-343-7593
University of Montreal
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. In Combination With FOLFOX4, the Effect of Erbitux and Avastin On Survival Rates Will Drive Prescription Decisions in the Treatment of Stage III Colon Cancer
2. Varian Medical Systems Announces Symposia on RapidArc Technology for Faster, More Precise Radiotherapy Treatments
3. No Difference Found in Treatments for Acute Kidney Failure
4. Missing Chromosome Improves Response to Brain Tumor Treatment
5. Combo Treatment Best for Melanoma, Advanced Ovarian Cancer
6. Yes, no, maybe so: New model helps identify what works in mental health treatment
7. USAID Awards $70 Million for the Prevention and Treatment of Obstetric Fistula
8. AIDS Healthcare Foundation and NCHADS Partnership Adds 8th Cambodian AIDS Treatment Center in Kirivong
9. Many Prostate Cancers Will Not Need Treatment
10. High-End Treatment Center Moonview Sanctuary Unveils Four New Core Treatment Programs
11. Respiratory Distress Treatment Studies Conflict
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2014)... Much of the research on post-combat mental health of ... and major depression. A paper co-authored by R. Tyson ... broader snapshot of returning soldiers, mental state by focusing ... from soldier to civilian life and how that conflict ... the January issue of Society and Mental Health ...
(Date:3/5/2014)... TALLAHASSEE, Fla. Frequent Facebook users might be sharing ... they also share a greater risk of eating ... State University researchers. , Psychology Professor Pamela K. Keel ... on Facebook was associated with higher levels of disordered ... and "likes" on their status updates and were more ...
(Date:3/5/2014)... program from UNC,s Frank Porter Graham Child Development Institute ... autism for life after high school. , "Public high ... for adolescents with autismand for their families," said FPG ... face unemployment and few social ties after school ends." ... the schools work hard to achieve beneficial results for ...
(Date:3/5/2014)... Barbara, Calif.) On the other side of the ... one follows the other can provide insight into the ... has focused on the pleasurable effects of cocaine largely ... left many questions unanswered. , So the Behavioral Pharmacology ... a different approach by examining the motivational systems that ...
(Date:3/4/2014)... at restoring the immune system,s ability to spot ... tumors in patients with advanced melanoma, according to ... Kimmel Cancer Center and 11 other institutions. All ... therapies, and most had received two or more ... the drug, nivolumab (anti-PD-1; BMS-936558; MDX-1106; ONO-4538), survived ...
Breaking Medicine News(10 mins):Health News:Returning vets face 'warring identities' distress 2Health News:Returning vets face 'warring identities' distress 3Health News:Hungry for 'likes': Frequent Facebook use linked to eating disorder risk, study finds 2Health News:New program for students with autism offers hope after high school 2Health News:UCSB study explores cocaine and the pleasure principle 2Health News:UCSB study explores cocaine and the pleasure principle 3Health News:Investigational drug may increase survival for some patients with advanced melanoma 2
... brain cells , , THURSDAY, April 24 (HealthDay News) -- German ... of the molecular "debris" that,s associated with the development of ... activity of an enzyme called beta-secretase -- is not new, ... cell biology at the Max Planck Institute of Molecular Cell ...
... WASHINGTON, April 24 At a briefing ... Plans (AHIP), health,plans showcased the value Medicare Advantage ... Medicare beneficiaries., (Logo: http://www.newscom.com/cgi-bin/prnh/20040830/AHIPLOGO ), ... SNP program beyond 2009 and,remove the existing moratorium ...
... Organization,s DC-Based Legislative,Initiatives, WASHINGTON, April 24 ... announced today the,appointment of Geoff Werth to its ... in the organization,s Washington, D.C.,office, Werth will focus ... order to advance public policies designed to improve ...
... play role in metabolic syndrome, studies say , , THURSDAY, ... protein, an inflammatory marker that may warn of impending ... control metabolism, two new studies show. , The studies ... either the treatment of cardiovascular disease or potentially screening ...
... from Labor Notes conference shows nonviolent,protest by women ... WASHINGTON, April 24 With raw video ... a nonviolent protest held,by mostly women and children, ... Palmer today called on AFL-CIO President John Sweeney,to ...
... STE ) today announced the appointment of two ... H. Fields have joined the STERIS,Board, expanding the number ... ten. Mr. Breeden will serve on the Board,s Compensation ... the Audit and,Financial Policy Committee., "We are pleased ...
Cached Medicine News:Health News:Study Details New Molecular Approach to Preventing Alzheimer's 2Health News:Study Details New Molecular Approach to Preventing Alzheimer's 3Health News:Health Plans Highlight Value of Medicare Advantage Special Needs Plans; Urge Congress to Extend Program 2Health News:US Oncology Welcomes New Director of Federal Government Relations 2Health News:New Heart Disease Markers Discovered 2Health News:New Heart Disease Markers Discovered 3Health News:New Heart Disease Markers Discovered 4Health News:SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions 2Health News:SEIU RN Dian Palmer Calls on AFL-CIO Head John Sweeney to Review Video From Dearborn Protest, Retract Statement Accepting CNA Distortions 3Health News:Steris Corporation Announces the Appointment of Two New Directors 2Health News:Steris Corporation Announces the Appointment of Two New Directors 3Health News:Steris Corporation Announces the Appointment of Two New Directors 4
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: ... less invasive, miniaturized circulatory support technologies that are ... announced that it expects revenues for the fourth ... bringing expected full-year 2013 revenues to approximately $208 ... 87% for 2013 above 2012 reflects the first ...
(Date:1/14/2014)... InformEx, North America,s ... high-value chemistry, will hold the 30 th edition ... Beach Convention Center from January 21-24. ... than 3,500 attendees from top pharmaceutical, fine chemical and ... which includes on-site education sessions, daily networking events and ...
(Date:1/14/2014)... , Jan. 14, 2014 Dynamic Healthcare Services, ... announced today that it acquired Progressive Home Medical Equipment, Inc. ... 7, 2014. The terms of the acquisition were not disclosed. ... equipment ("DME") company providing a wide range of sleep, mobility, ... Pennsylvania and Pittsburgh markets. ...
Breaking Medicine Technology:HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... December 8 ,Agendia, a world leader in molecular ... Netherlands Cancer Institute researchers will present,data from multiple ... Symposium,(SABCS) and Agendia will support, with an unrestricted ... symposium. The San Antonio,Breast Cancer Symposium, one of ...
... Compared to Topical Anaesthetic Xylocaine(R) , ... ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) today announced the successful ... the ability of its patented drug delivery system, TPM, ... into humans. The trial demonstrated that the patented lidocaine ...
Cached Medicine Technology:Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 2Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 3Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium 4Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine 2Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: